Trial intelligence / Profile preview

Efficacy of Lacosamide and Topiramate on Control of Neonatal Refractory Seizures

IRCT20230415057911N2Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Mar 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of lacosamide and topiramate in neonatal seizure, sponsored by Iran University of Medical Sciences. Started Mar 2023; status: completed.

02

Drugs

lacosamidetopiramate
03

Conditions

neonatal seizure

Beyond the preview

Go deeper on IRCT20230415057911N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230415057911N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call